What You Should Know:
- Vivalink is addressing these RPM interoperability challenges by announcing today that leading wearables and medical-grade devices are integrating with the company’s Biometrics Data Platform.
- Now, leading pulse oximeters, blood glucose monitors and sleep monitors by companies like Garmin and Roche are available alongside the Platform to accelerate development and deployment of novel healthcare applications and research.
Why It Matters
Integration and
Read More
Cardiac Monitoring
HCA Makes Strategic Investment in Cardiac Monitoring Wearable VitalConnect
What You Should Know:
- VitalConnect®, Inc., a leader in remote and in-hospital wearable biosensor technology, has just announced the completion of an investment funded by Health Insight Capital, the investment arm of HCA Healthcare Inc., (NYSE: HCA), one of the nation’s leading healthcare providers.
- The investment will go toward further accelerating VitalConnect’s rapidly growing cardiac monitoring business segment while advancing key Remote Patient Monitoring of individuals who
Read More
Sibel Health Raises $33M for Advanced Wearable Sensors for RPM
What You Should Know:
- Sibel Health has recently closed a $33M Series B financing round, bringing Sibel's total funding to date to more than $50M.
- In addition, Sibel has announced two new executive appointments. Jon Otterstatter, the former CEO and co-founder of Preventice (acquired by Boston Scientific in 2021), will join as chairman of the board. Matthew Banet, Ph.D., a world expert in advanced body-worn sensors and previously the CTO and co-founder of toSense and Sotera, joins as
Read More
Biotricity Awarded FDA 510(k) Clearance for Cardiac Monitoring Device
What You Should Know:
- Biotricity, Inc. (NASDAQ:BTCY), a medical diagnostic and consumer healthcare technology company, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Biotres Cardiac Monitoring Device, a three-lead device for ECG and arrhythmia monitoring that is intended for lower-risk patients.
- Most remote cardiac monitors are passive — they don’t record ECG and other cardiac data in real-time — and lack cross-compatibility
Read More
Philips Acquires Cardiologs to Expand Cardiac Diagnostics & Monitoring Portfolio
What You Should Know:
- Philips today announced that it has signed an agreement to acquire Paris-based Cardiologs, a France-based medical technology company focused on transforming cardiac diagnostics using artificial intelligence (AI) and cloud technology.
- Cardiologs will further strengthen Philips’ cardiac monitoring and diagnostics offering with innovative software technology, electrocardiogram (ECG) analysis and reporting services. Financial details of the acquisition were not
Read More
Eko Launches Next Generation DUO ECG + Digital Stethoscope for Frontline Clinicians
What You Should Know:
- Eko, a cardiopulmonary digital health company launches its next-generation Eko DUO, an FDA-cleared cardiac assessment tool that functions as an electrocardiogram (ECG) and digital stethoscope to detect early signs of heart disease and facilitate timely care and personalized disease management.
- DUO is a pocket-sized cardiac examination system for clinicians used to detect early signs of heart disease and facilitate timely care for patients in and out of the clinic.
Read More
Ultromics Raises $33M for AI-Enabled Echocardiograms to Help Clinicians Diagnose Heart Disease
What You Should Know:
- Today, Ultromics, an Oxford, England-based health-tech startup announced it has raised $33M in Series B funding led by Blue Ventures, the investing arm of Blue Cross Blue Shield, and also includes investment from Optum Ventures, GV, and Oxford Sciences.
- Born at the University of Oxford and built-in partnership with the U.K.’s NHS, Ultromics has developed the first fully automated solution for echocardiography and analysis of global longitudinal strain (GLS).
Read More
Medtronic Awarded FDA Clearance for 2 AI Algorithms for Cardiac Monitoring
What You Should Know:
- Medtronic announced U.S. Food and Drug Administration (FDA) clearance for two AccuRhythm™ AI algorithms for use with the LINQ II™ insertable cardiac monitor (ICM) – and the presentation of AccuRhythm AI validation data this week at Heart Rhythm 2021.
- AccuRhythm AI applies artificial intelligence (AI) to heart rhythm event data collected by LINQ II, improving the accuracy of information physicians receive so they can better diagnose and treat abnormal heart
Read More
Could ‘Hospitals Without Walls’ Be the New Normal for Telehealth and Remote Patient Monitoring?
The statistics surrounding the COVID-19 pandemic continue to be startling, despite the ever-growing mental and physical fatigue that we’ve all experienced living through this frightening, intimidating and unprecedented era. More than 125 million cases worldwide have resulted in a death toll closing in on three million, while in the United States alone, 30 million reported infections have resulted in a death toll that reached 550,000. (1) One thing that can be said for certain about
Read More
The Future of Remote Care Automation Begins with Cardiac Rehabilitation
2020 was undeniably the year that saw telehealth and remote care services come to the forefront of medical care. Many have hypothesized that, in the post-COVID world, remote care programs will be ubiquitous throughout hospitals and health systems. However, such a future is far from certain, as too many organizations currently lack the budget, IT infrastructure, and time necessary to implement new innovative remote care programs. There is a considerable disparity between the hype surrounding
Read More
